世界のオレキシン受容体タイプ2市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Orexin Receptor Type 2 Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A15048 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、84ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、オレキシン受容体タイプ2のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オレキシン受容体タイプ2の種類別市場規模（）、用途別市場規模（不眠症、ナルコレプシー、睡眠障害、うつ病性障害）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・オレキシン受容体タイプ2の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Actelion Pharmaceuticals Ltd、Eisai Co Ltd、Evotec AG、Heptares Therapeutics Ltd、Idorsia Ltd、Johnson & Johnson、Merck & Co Inc、OptiNose US Inc、Yangtze River Pharmaceutical Group ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年： ・用途別分析2016年-2026年：不眠症、ナルコレプシー、睡眠障害、うつ病性障害 ・オレキシン受容体タイプ2の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・オレキシン受容体タイプ2のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・オレキシン受容体タイプ2のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オレキシン受容体タイプ2の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・オレキシン受容体タイプ2の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Orexin Receptor Type 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Orexin Receptor Type 2 size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Orexin Receptor Type 2 market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Orexin Receptor Type 2 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others

Market segment by Application, can be divided into
Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder

Market segment by players, this report covers
Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Orexin Receptor Type 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Orexin Receptor Type 2, with revenue, gross margin and global market share of Orexin Receptor Type 2 from 2019 to 2021.
Chapter 3, the Orexin Receptor Type 2 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Orexin Receptor Type 2 market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Orexin Receptor Type 2 research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Orexin Receptor Type 2
1.2 Classification of Orexin Receptor Type 2 by Type
1.2.1 Overview: Global Orexin Receptor Type 2 Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Orexin Receptor Type 2 Revenue Market Share by Type in 2020
1.2.3 HTL-6641
1.2.4 MK-8133
1.2.5 Lemborexant
1.2.6 OPN-021
1.2.7 YNT-185
1.2.8 Others
1.3 Global Orexin Receptor Type 2 Market by Application
1.3.1 Overview: Global Orexin Receptor Type 2 Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Insomnia
1.3.3 Narcolepsy
1.3.4 Sleep Disorders
1.3.5 Major Depressive Disorder
1.4 Global Orexin Receptor Type 2 Market Size & Forecast
1.5 Global Orexin Receptor Type 2 Market Size and Forecast by Region
1.5.1 Global Orexin Receptor Type 2 Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Orexin Receptor Type 2 Market Size by Region, (2016-2021)
1.5.3 North America Orexin Receptor Type 2 Market Size and Prospect (2016-2026)
1.5.4 Europe Orexin Receptor Type 2 Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Orexin Receptor Type 2 Market Size and Prospect (2016-2026)
1.5.6 South America Orexin Receptor Type 2 Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Orexin Receptor Type 2 Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Orexin Receptor Type 2 Market Drivers
1.6.2 Orexin Receptor Type 2 Market Restraints
1.6.3 Orexin Receptor Type 2 Trends Analysis
2 Company Profiles
2.1 Actelion Pharmaceuticals Ltd
2.1.1 Actelion Pharmaceuticals Ltd Details
2.1.2 Actelion Pharmaceuticals Ltd Major Business
2.1.3 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product and Solutions
2.1.4 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Actelion Pharmaceuticals Ltd Recent Developments and Future Plans
2.2 Eisai Co Ltd
2.2.1 Eisai Co Ltd Details
2.2.2 Eisai Co Ltd Major Business
2.2.3 Eisai Co Ltd Orexin Receptor Type 2 Product and Solutions
2.2.4 Eisai Co Ltd Orexin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Eisai Co Ltd Recent Developments and Future Plans
2.3 Evotec AG
2.3.1 Evotec AG Details
2.3.2 Evotec AG Major Business
2.3.3 Evotec AG Orexin Receptor Type 2 Product and Solutions
2.3.4 Evotec AG Orexin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Evotec AG Recent Developments and Future Plans
2.4 Heptares Therapeutics Ltd
2.4.1 Heptares Therapeutics Ltd Details
2.4.2 Heptares Therapeutics Ltd Major Business
2.4.3 Heptares Therapeutics Ltd Orexin Receptor Type 2 Product and Solutions
2.4.4 Heptares Therapeutics Ltd Orexin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Heptares Therapeutics Ltd Recent Developments and Future Plans
2.5 Idorsia Ltd
2.5.1 Idorsia Ltd Details
2.5.2 Idorsia Ltd Major Business
2.5.3 Idorsia Ltd Orexin Receptor Type 2 Product and Solutions
2.5.4 Idorsia Ltd Orexin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Idorsia Ltd Recent Developments and Future Plans
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Orexin Receptor Type 2 Product and Solutions
2.6.4 Johnson & Johnson Orexin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Johnson & Johnson Recent Developments and Future Plans
2.7 Merck & Co Inc
2.7.1 Merck & Co Inc Details
2.7.2 Merck & Co Inc Major Business
2.7.3 Merck & Co Inc Orexin Receptor Type 2 Product and Solutions
2.7.4 Merck & Co Inc Orexin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Merck & Co Inc Recent Developments and Future Plans
2.8 OptiNose US Inc
2.8.1 OptiNose US Inc Details
2.8.2 OptiNose US Inc Major Business
2.8.3 OptiNose US Inc Orexin Receptor Type 2 Product and Solutions
2.8.4 OptiNose US Inc Orexin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 OptiNose US Inc Recent Developments and Future Plans
2.9 Yangtze River Pharmaceutical Group
2.9.1 Yangtze River Pharmaceutical Group Details
2.9.2 Yangtze River Pharmaceutical Group Major Business
2.9.3 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product and Solutions
2.9.4 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Yangtze River Pharmaceutical Group Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Orexin Receptor Type 2 Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Orexin Receptor Type 2 Players Market Share
3.2.2 Top 10 Orexin Receptor Type 2 Players Market Share
3.2.3 Market Competition Trend
3.3 Orexin Receptor Type 2 Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Orexin Receptor Type 2 Revenue and Market Share by Type (2016-2021)
4.2 Global Orexin Receptor Type 2 Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Orexin Receptor Type 2 Revenue Market Share by Application (2016-2021)
5.2 Orexin Receptor Type 2 Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Orexin Receptor Type 2 Revenue by Type (2016-2026)
6.2 North America Orexin Receptor Type 2 Revenue by Application (2016-2026)
6.3 North America Orexin Receptor Type 2 Market Size by Country
6.3.1 North America Orexin Receptor Type 2 Revenue by Country (2016-2026)
6.3.2 United States Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
6.3.3 Canada Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
6.3.4 Mexico Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Orexin Receptor Type 2 Revenue by Type (2016-2026)
7.2 Europe Orexin Receptor Type 2 Revenue by Application (2016-2026)
7.3 Europe Orexin Receptor Type 2 Market Size by Country
7.3.1 Europe Orexin Receptor Type 2 Revenue by Country (2016-2026)
7.3.2 Germany Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
7.3.3 France Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
7.3.5 Russia Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
7.3.6 Italy Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Orexin Receptor Type 2 Revenue by Type (2016-2026)
8.2 Asia-Pacific Orexin Receptor Type 2 Revenue by Application (2016-2026)
8.3 Asia-Pacific Orexin Receptor Type 2 Market Size by Region
8.3.1 Asia-Pacific Orexin Receptor Type 2 Revenue by Region (2016-2026)
8.3.2 China Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
8.3.3 Japan Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
8.3.4 South Korea Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
8.3.5 India Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
8.3.7 Australia Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Orexin Receptor Type 2 Revenue by Type (2016-2026)
9.2 South America Orexin Receptor Type 2 Revenue by Application (2016-2026)
9.3 South America Orexin Receptor Type 2 Market Size by Country
9.3.1 South America Orexin Receptor Type 2 Revenue by Country (2016-2026)
9.3.2 Brazil Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
9.3.3 Argentina Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Orexin Receptor Type 2 Revenue by Type (2016-2026)
10.2 Middle East & Africa Orexin Receptor Type 2 Revenue by Application (2016-2026)
10.3 Middle East & Africa Orexin Receptor Type 2 Market Size by Country
10.3.1 Middle East & Africa Orexin Receptor Type 2 Revenue by Country (2016-2026)
10.3.2 Turkey Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
10.3.4 UAE Orexin Receptor Type 2 Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Orexin Receptor Type 2 Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Orexin Receptor Type 2 Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Orexin Receptor Type 2 Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Orexin Receptor Type 2 Revenue (USD Million) by Region (2016-2021)
Table 5. Global Orexin Receptor Type 2 Revenue Market Share by Region (2021-2026)
Table 6. Actelion Pharmaceuticals Ltd Corporate Information, Head Office, and Major Competitors
Table 7. Actelion Pharmaceuticals Ltd Major Business
Table 8. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product and Solutions
Table 9. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Eisai Co Ltd Corporate Information, Head Office, and Major Competitors
Table 11. Eisai Co Ltd Major Business
Table 12. Eisai Co Ltd Orexin Receptor Type 2 Product and Solutions
Table 13. Eisai Co Ltd Orexin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Evotec AG Corporate Information, Head Office, and Major Competitors
Table 15. Evotec AG Major Business
Table 16. Evotec AG Orexin Receptor Type 2 Product and Solutions
Table 17. Evotec AG Orexin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Heptares Therapeutics Ltd Corporate Information, Head Office, and Major Competitors
Table 19. Heptares Therapeutics Ltd Major Business
Table 20. Heptares Therapeutics Ltd Orexin Receptor Type 2 Product and Solutions
Table 21. Heptares Therapeutics Ltd Orexin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Idorsia Ltd Corporate Information, Head Office, and Major Competitors
Table 23. Idorsia Ltd Major Business
Table 24. Idorsia Ltd Orexin Receptor Type 2 Product and Solutions
Table 25. Idorsia Ltd Orexin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 27. Johnson & Johnson Major Business
Table 28. Johnson & Johnson Orexin Receptor Type 2 Product and Solutions
Table 29. Johnson & Johnson Orexin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Merck & Co Inc Corporate Information, Head Office, and Major Competitors
Table 31. Merck & Co Inc Major Business
Table 32. Merck & Co Inc Orexin Receptor Type 2 Product and Solutions
Table 33. Merck & Co Inc Orexin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. OptiNose US Inc Corporate Information, Head Office, and Major Competitors
Table 35. OptiNose US Inc Major Business
Table 36. OptiNose US Inc Orexin Receptor Type 2 Product and Solutions
Table 37. OptiNose US Inc Orexin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Yangtze River Pharmaceutical Group Corporate Information, Head Office, and Major Competitors
Table 39. Yangtze River Pharmaceutical Group Major Business
Table 40. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product and Solutions
Table 41. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Orexin Receptor Type 2 Revenue (USD Million) by Players (2019-2021)
Table 43. Global Orexin Receptor Type 2 Revenue Share by Players (2019-2021)
Table 44. Breakdown of Orexin Receptor Type 2 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Orexin Receptor Type 2 Players Head Office, Products and Services Provided
Table 46. Orexin Receptor Type 2 Mergers & Acquisitions in the Past Five Years
Table 47. Orexin Receptor Type 2 New Entrants and Expansion Plans
Table 48. Global Orexin Receptor Type 2 Revenue (USD Million) by Type (2016-2021)
Table 49. Global Orexin Receptor Type 2 Revenue Share by Type (2016-2021)
Table 50. Global Orexin Receptor Type 2 Revenue Forecast by Type (2021-2026)
Table 51. Global Orexin Receptor Type 2 Revenue by Application (2016-2021)
Table 52. Global Orexin Receptor Type 2 Revenue Forecast by Application (2021-2026)
Table 53. North America Orexin Receptor Type 2 Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Orexin Receptor Type 2 Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Orexin Receptor Type 2 Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Orexin Receptor Type 2 Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Orexin Receptor Type 2 Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Orexin Receptor Type 2 Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Orexin Receptor Type 2 Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Orexin Receptor Type 2 Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Orexin Receptor Type 2 Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Orexin Receptor Type 2 Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Orexin Receptor Type 2 Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Orexin Receptor Type 2 Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Orexin Receptor Type 2 Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Orexin Receptor Type 2 Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Orexin Receptor Type 2 Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Orexin Receptor Type 2 Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Orexin Receptor Type 2 Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Orexin Receptor Type 2 Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Orexin Receptor Type 2 Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Orexin Receptor Type 2 Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Orexin Receptor Type 2 Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Orexin Receptor Type 2 Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Orexin Receptor Type 2 Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Orexin Receptor Type 2 Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Orexin Receptor Type 2 Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Orexin Receptor Type 2 Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Orexin Receptor Type 2 Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Orexin Receptor Type 2 Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Orexin Receptor Type 2 Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Orexin Receptor Type 2 Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Orexin Receptor Type 2 Picture
Figure 2. Global Orexin Receptor Type 2 Revenue Market Share by Type in 2020
Figure 3. HTL-6641
Figure 4. MK-8133
Figure 5. Lemborexant
Figure 6. OPN-021
Figure 7. YNT-185
Figure 8. Others
Figure 9. Orexin Receptor Type 2 Revenue Market Share by Application in 2020
Figure 10. Insomnia Picture
Figure 11. Narcolepsy Picture
Figure 12. Sleep Disorders Picture
Figure 13. Major Depressive Disorder Picture
Figure 14. Global Orexin Receptor Type 2 Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Orexin Receptor Type 2 Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Orexin Receptor Type 2 Revenue Market Share by Region (2016-2026)
Figure 17. Global Orexin Receptor Type 2 Revenue Market Share by Region in 2020
Figure 18. North America Orexin Receptor Type 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Orexin Receptor Type 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Orexin Receptor Type 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Orexin Receptor Type 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Orexin Receptor Type 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Orexin Receptor Type 2 Market Drivers
Figure 24. Orexin Receptor Type 2 Market Restraints
Figure 25. Orexin Receptor Type 2 Market Trends
Figure 26. Actelion Pharmaceuticals Ltd Recent Developments and Future Plans
Figure 27. Eisai Co Ltd Recent Developments and Future Plans
Figure 28. Evotec AG Recent Developments and Future Plans
Figure 29. Heptares Therapeutics Ltd Recent Developments and Future Plans
Figure 30. Idorsia Ltd Recent Developments and Future Plans
Figure 31. Johnson & Johnson Recent Developments and Future Plans
Figure 32. Merck & Co Inc Recent Developments and Future Plans
Figure 33. OptiNose US Inc Recent Developments and Future Plans
Figure 34. Yangtze River Pharmaceutical Group Recent Developments and Future Plans
Figure 35. Global Orexin Receptor Type 2 Revenue Share by Players in 2020
Figure 36. Orexin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Orexin Receptor Type 2 Revenue Market Share in 2020
Figure 38. Global Top 10 Players Orexin Receptor Type 2 Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Orexin Receptor Type 2 Revenue Share by Type in 2020
Figure 41. Global Orexin Receptor Type 2 Market Share Forecast by Type (2021-2026)
Figure 42. Global Orexin Receptor Type 2 Revenue Share by Application in 2020
Figure 43. Global Orexin Receptor Type 2 Market Share Forecast by Application (2021-2026)
Figure 44. North America Orexin Receptor Type 2 Sales Market Share by Type (2016-2026)
Figure 45. North America Orexin Receptor Type 2 Sales Market Share by Application (2016-2026)
Figure 46. North America Orexin Receptor Type 2 Revenue Market Share by Country (2016-2026)
Figure 47. United States Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Orexin Receptor Type 2 Sales Market Share by Type (2016-2026)
Figure 51. Europe Orexin Receptor Type 2 Sales Market Share by Application (2016-2026)
Figure 52. Europe Orexin Receptor Type 2 Revenue Market Share by Country (2016-2026)
Figure 53. Germany Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Orexin Receptor Type 2 Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Orexin Receptor Type 2 Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Orexin Receptor Type 2 Revenue Market Share by Region (2016-2026)
Figure 61. China Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Orexin Receptor Type 2 Sales Market Share by Type (2016-2026)
Figure 68. South America Orexin Receptor Type 2 Sales Market Share by Application (2016-2026)
Figure 69. South America Orexin Receptor Type 2 Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Orexin Receptor Type 2 Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Orexin Receptor Type 2 Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Orexin Receptor Type 2 Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Orexin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source

---